XJA-24725-76389
2 vaccinations
2 coded responses
11 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 444 / OH
- Registered
- 2021-03-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-25
Registered in v-safe
-
2021-03-25
Dose 1 — Moderna
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-31
- 2021-04-16
-
2021-04-22
Dose 2 — Moderna
- 2021-04-22
-
2021-04-23
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body achesAdult check-in
-
2021-05-06
Survey response — day 14, dose 2MedDRA: Cough, Dyspnoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Bad cough, shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-10-21
Survey response — 6 months, dose 2MedDRA: Chills, Cough, Headache, Nausea, Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Fever, chills, headache, nausea, cough, congestionMedDRA releases: 2024-11 · check-in free text available
-
2021-10-21
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-25 | Moderna | |
| 2 | 2021-04-22 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-21 | Unsuccessful |
Free text
Release 8 — day 14, dose 2
Symptoms: Bad cough, shortness of breath
Release 10 — 6 months, dose 2
Symptoms: Fever, chills, headache, nausea, cough, congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release